biosimilarsconference.be
Biosimilars Conference
The Belgian Biosimilars Conference. From clinical experience to practical implementation. 15 April 2016 Promotiezaal, KU Leuven. In light of the recently concluded Convenant voor de doorstart voor biosimilaire geneesmiddelen in België/Convention sur la relance des médicaments biosimilaires en Belgique , the conference focuses on how physicians and hospital management can practically start implementing biosimilars in Belgian hospitals. Conference chair: Prof. Dr. René Westhovens. Prof Dr. Geert D’Haens.
biosimilarscouncil.org
The Biosimilars Council | A Division of GPhA
About the Biosimilars Council. The GPhA Biosimilars Council works to ensure a positive regulatory, reimbursement, political and policy environment for biosimilar products, and will educate the public and patients about the safety and effectiveness of biosimilars. Areas of focus will include education, access, the nascent regulatory environment, reimbursement and legal affairs. Member organizations include any company or stakeholder organization working to develop biosimilar products with the inte...
biosimilarsdatabase.com
biosimilarsdatabase.com - This website is for sale! - biosimilars Resources and Information.
The owner of biosimilarsdatabase.com. Is offering it for sale for an asking price of 1350 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
biosimilarseurope.com
Biosimilars Europe Congress 2017 | Global Event in Biosimilars and Biobetters | International Conference at London, U.K on 21 Nov 2017
Download 2017 Sales Brochure. Become a Sponsor / Exhibit. 2016 Sponsor and Exhibitors. Navigating through the new waves of Biologics. Developing Biosimilars Market in Europe. Your browser does not support the video tag. I suggest you upgrade your browser. Head Global Medical Affairs Biosimilars. Marketing Director - Provantage E2E Services Process Solutions. Senior Regulatory Affairs Manager. Dr Mourad Farouk Rezk MD. Global Head Medical Affairs Biosimilars. Lead Risk Management, Global Pharmacovigilance.
biosimilarsgroup.biz
The Biosimilars Group
MORE ABOUT OUR OFFER. OUR NEW UNIQUE OFFER:. THE TBG ONE-DAY WORKSHOP. Get a tailor-made project plan. For your biosimilar of your choice! The Biosimilars Group is a one-stop solution provider to realize complex biosimilar projects tailored to your specific requirements. From Cell to Marketing Authorization -. Combined Excellence in Biosimilars Development. DISCOVER MORE ABOUT US. The Biosimilars Group is covering all aspects of biosimilars development from candidate identification to marketed product.
biosimilarsgroup.com
The Biosimilars Group
MORE ABOUT OUR OFFER. OUR NEW UNIQUE OFFER:. THE TBG ONE-DAY WORKSHOP. Get a tailor-made project plan. For your biosimilar of your choice! The Biosimilars Group is a one-stop solution provider to realize complex biosimilar projects tailored to your specific requirements. From Cell to Marketing Authorization -. Combined Excellence in Biosimilars Development. DISCOVER MORE ABOUT US. The Biosimilars Group is covering all aspects of biosimilars development from candidate identification to marketed product.
biosimilarsgroup.net
The Biosimilars Group
MORE ABOUT OUR OFFER. OUR NEW UNIQUE OFFER:. THE TBG ONE-DAY WORKSHOP. Get a tailor-made project plan. For your biosimilar of your choice! The Biosimilars Group is a one-stop solution provider to realize complex biosimilar projects tailored to your specific requirements. From Cell to Marketing Authorization -. Combined Excellence in Biosimilars Development. DISCOVER MORE ABOUT US. The Biosimilars Group is covering all aspects of biosimilars development from candidate identification to marketed product.
biosimilarslawblog.com
Biosimilars Law Blog | Pharmaceutical Lawyers | Hogan Lovells
With more than 100 lawyers serving the pharmaceutical and biotechnology sectors, we offer timely, effective counsel on a wide variety of matters. Continue Reading ». June 30th, 2017. Posted in News and Events. Biosimilars Presentation at Sino-American Pharmaceutical Conference. On June 24, 2017, Hogan Lovells attorneys Xin Tao. Washington DC Office) and Liang Xu. This event drew over 1,000 people from both the Chinese and U.S. pharmaceutical industry. Link to the event is available here. June 13th, 2017.
biosimilarsnews.com
biosimilarsnews.com - This website is for sale! - biosimilarsnews Resources and Information.
The owner of biosimilarsnews.com. Is offering it for sale for an asking price of 1350 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
biosimilarspipeline.com
Biosimilars/Biobetters Pipeline Directory
The most comprehensive and cost-effective follow-on biopharmaceuticals (biosimilars, biobetters and biogenerics) pipeline resource. Find competing products and companies; product/API licensing sources; collaborators and partners; customers for your products, technologies and services. Over 1,550 product records: 875 biosimilars, 525 biobetters, 149 reference products; plus 700 involved company records [1/1/2018]. Available in multiple formats:. Developed by the author. Enter password for database access:.
biosimilarsregister.com
biosimilarsregister.com - This website is for sale! - biosimilars Resources and Information.
The owner of biosimilarsregister.com. Is offering it for sale for an asking price of 1350 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
